PRECIVITYTAUDX Trademark
Trademark Overview
On Saturday, December 14, 2024, a trademark application was filed for PRECIVITYTAUDX with the United States Patent and Trademark Office. The USPTO has given the PRECIVITYTAUDX trademark a serial number of 98903251. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Saturday, December 14, 2024. This trademark is owned by C2N Diagnostics, LLC. The PRECIVITYTAUDX trademark is filed in the Pharmaceutical Products and Medical & Beauty Services & Agricultural Services categories with the following description:
Medical diagnostic reagents, assays, and algorithms for testing bodily fluids; diagnostic testing kits comprised of diagnostic reagents, assays and specimen holders for testing of bodily fluids for use in disease or pathology detection, diagnosing, staging, predicting future events, predicting or measuring disease progression, assessing treatment response, monitoring, reporting, treating, and prevention, namely, neurodegenerative diseases and neurological diseases
Medical testing for diagnostic, prognostic, monitoring or treatment purposes; medical laboratory, diagnostic testing, disease or pathology staging, predicting, monitoring, and reporting services; medical testing for disease, illness, pathology, and pathology treatment tracking, predicting, treating and prevention purposes
General Information
Serial Number | 98903251 |
Word Mark | PRECIVITYTAUDX |
Filing Date | Saturday, December 14, 2024 |
Status | 630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER |
Status Date | Saturday, December 14, 2024 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
Goods and Services | Medical diagnostic reagents, assays, and algorithms for testing bodily fluids; diagnostic testing kits comprised of diagnostic reagents, assays and specimen holders for testing of bodily fluids for use in disease or pathology detection, diagnosing, staging, predicting future events, predicting or measuring disease progression, assessing treatment response, monitoring, reporting, treating, and prevention, namely, neurodegenerative diseases and neurological diseases |
Goods and Services | Medical testing for diagnostic, prognostic, monitoring or treatment purposes; medical laboratory, diagnostic testing, disease or pathology staging, predicting, monitoring, and reporting services; medical testing for disease, illness, pathology, and pathology treatment tracking, predicting, treating and prevention purposes |
Classification Information
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Saturday, December 14, 2024 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
US Class Codes | 100, 101 |
Class Status Code | 6 - Active |
Class Status Date | Saturday, December 14, 2024 |
Primary Code | 044 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
Party Name | C2N Diagnostics, LLC |
Party Type | 10 - Original Applicant |
Legal Entity Type | 16 - Limited Liability Company |
Address | St. Louis, MO 63110 |
Trademark Events
Event Date | Event Description |
Saturday, December 14, 2024 | NEW APPLICATION ENTERED |